SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Kohler Kenneth E (Last) (First) (Middle) C/O 70 SIR JOHN ROGERSON'S QUAY (Street) DUBLIN L2 2 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 02/22/2024	3. Issuer Name and Ticker or Trading Symbol STERIS plc [ STE ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP & GM, AST	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	2,210(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (right to buy)	(2)	05/31/2029	Ordinary Shares	2,136	$147.05	D
Employee Stock Options (right to buy)	(3)	06/01/2030	Ordinary Shares	3,728	$182.22	D
Employee Stock Options (right to buy)	(4)	06/02/2031	Ordinary Shares	2,764	$210.3	D
Employee Stock Options (right to buy)	(5)	06/02/2032	Ordinary Shares	4,100	$250.06	D
Employee Stock Options (right to buy)	(6)	05/31/2033	Ordinary Shares	4,192	$219.97	D

Explanation of Responses:

1. As of February 23, 2024, 2,210 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 373 on May 31, 2024; 154 on June 1, 2024; 131 on June 2, 2024; 225 on June 2, 2024; 373 on May 31, 2025; 131 on June 2, 2025; 225 on June 2, 2025; 373 on May 31, 2026; 225 on June 2, 2026.

2. This option is fully vested and exercisable.

3. 2,796 of these options are exercisable. This option becomes exercisable as follows: 932 on June 1, 2024.

4. 1,382 of these options are exercisable. This option becomes exercisable as follows: 691 on June 2, 2024; 691 on June 2, 2025.

5. 1,025 of these options are exercisable. This option becomes exercisable as follows: 1,025 on June 2, 2024; 1,025 on June 2, 2025 and 1,025 on June 1, 2026.

6. This option becomes exercisable as follows: 1,048 on May 31, 2024; 1,048 on May 31, 2025; 1,048 on May 31, 2026 and 1,048 on May 31, 2027.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	02/23/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.